Insider Buying: Vital Farms (NASDAQ:VITL) Director Purchases $50,813.00 in Stock

Vital Farms, Inc. (NASDAQ:VITL) Director Glenda Flanagan bought 6,100 shares of the stock in a transaction on Monday, May 18th. The stock was purchased at an average price of $8.33 per share, for a total transaction of $50,813.00. Following the completion of the purchase, the director owned 37,498 shares of the company’s stock, valued at approximately $312,358.34. This trade represents a 19.43% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.

Vital Farms Stock Performance

Shares of VITL opened at $10.13 on Friday. The firm has a market cap of $434.07 million, a PE ratio of 9.74 and a beta of 1.20. The stock’s fifty day moving average price is $12.41 and its two-hundred day moving average price is $23.44. The company has a debt-to-equity ratio of 0.01, a current ratio of 1.77 and a quick ratio of 1.00. Vital Farms, Inc. has a 1 year low of $7.95 and a 1 year high of $53.13.

Vital Farms (NASDAQ:VITL) last issued its earnings results on Thursday, May 7th. The company reported ($0.03) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.09 by ($0.12). The firm had revenue of $187.16 million during the quarter, compared to the consensus estimate of $182.40 million. Vital Farms had a net margin of 6.10% and a return on equity of 14.47%. The business’s quarterly revenue was up 15.4% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.37 earnings per share. On average, equities research analysts forecast that Vital Farms, Inc. will post -0.45 EPS for the current year.

Hedge Funds Weigh In On Vital Farms

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Granite Investment Partners LLC grew its position in Vital Farms by 0.7% during the third quarter. Granite Investment Partners LLC now owns 59,114 shares of the company’s stock worth $2,433,000 after buying an additional 427 shares in the last quarter. Advisors Asset Management Inc. grew its position in Vital Farms by 1.4% during the fourth quarter. Advisors Asset Management Inc. now owns 34,072 shares of the company’s stock worth $1,088,000 after buying an additional 479 shares in the last quarter. Van ECK Associates Corp grew its position in Vital Farms by 7.7% during the fourth quarter. Van ECK Associates Corp now owns 6,912 shares of the company’s stock worth $221,000 after buying an additional 495 shares in the last quarter. Clean Yield Group grew its position in Vital Farms by 0.9% during the fourth quarter. Clean Yield Group now owns 65,406 shares of the company’s stock worth $2,089,000 after buying an additional 596 shares in the last quarter. Finally, Caitong International Asset Management Co. Ltd grew its position in Vital Farms by 47.4% during the fourth quarter. Caitong International Asset Management Co. Ltd now owns 1,957 shares of the company’s stock worth $63,000 after buying an additional 629 shares in the last quarter. 98.59% of the stock is currently owned by hedge funds and other institutional investors.

Key Stories Impacting Vital Farms

Here are the key news stories impacting Vital Farms this week:

• Positive Sentiment: Director Glenda Flanagan and insider Hoven Reena Chauhan Van both bought shares recently, signaling some internal confidence in Vital Farms after the post-earnings selloff. Article Title
• Neutral Sentiment: The company’s latest quarter missed earnings expectations but beat on revenue, leaving investors focused on mixed fundamentals after the May 7 report. Article Title
• Negative Sentiment: Multiple law firms, including Berger Montague, Faruqi & Faruqi, Schall, Pomerantz, Rosen, and Robbins, are urging investors to join or inquire about a securities class action tied to alleged misconduct during the May 2025 to February 2026 period. Article Title
• Negative Sentiment: The lawsuits allege Vital Farms executives concealed shipment disruptions and misled investors about business prospects, adding legal uncertainty ahead of the May 26 lead-plaintiff deadline. Article Title

Wall Street Analysts Forecast Growth

Several equities analysts have recently weighed in on the company. Zacks Research cut Vital Farms from a “hold” rating to a “strong sell” rating in a research report on Monday, March 2nd. Needham & Company LLC reduced their price target on Vital Farms from $20.00 to $13.00 and set a “buy” rating for the company in a research report on Monday, May 11th. DA Davidson reiterated a “neutral” rating and issued a $16.00 price target (down from $47.00) on shares of Vital Farms in a research report on Monday, May 4th. Stifel Nicolaus reiterated a “hold” rating and issued a $10.00 price target (down from $34.00) on shares of Vital Farms in a research report on Friday, May 8th. Finally, Morgan Stanley set a $10.00 price target on Vital Farms in a research report on Friday, May 8th. Five analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $27.33.

About Vital Farms

Vital Farms, traded on the NASDAQ under the symbol VITL, is a U.S.-based food company specializing in pasture-raised egg and dairy products. The company partners with a network of family farms across the United States to produce eggs, butter and related items under a certified humane, pasture-centric farming model. Vital Farms’ supply chain emphasizes animal welfare, environmental stewardship and transparent sourcing, appealing to consumers seeking ethically produced, high-quality ingredients.

Founded in 2007 and headquartered in Austin, Texas, Vital Farms began by marketing pasture-raised eggs to health- and ethically minded shoppers.